These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34724213)

  • 41. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined Nasal, Oropharyngeal Povidone Iodine Plus Glycyrrhizic Acid Sprays, Accelerate Clinical and Laboratory Recovery and Reduces Household Transmission of SARS-CoV-2: A Randomized Placebo-Controlled Clinical Trial.
    Elsersy HE; Zahran MAH; Elbakry AE; Abd-Elwahab M; Ahmed MM; Elgandy MS; Mohammed EHM; Elewa NM
    Front Med (Lausanne); 2022; 9():863917. PubMed ID: 35514746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19.
    Matsuyama A; Okura H; Hashimoto S; Tanaka T
    Sci Rep; 2022 Nov; 12(1):20449. PubMed ID: 36443363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.
    Chorney SR; Rizzi MD; Dedhia K
    Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
    Schütz D; Conzelmann C; Fois G; Groß R; Weil T; Wettstein L; Stenger S; Zelikin A; Hoffmann TK; Frick M; Müller JA; Münch J
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L750-L756. PubMed ID: 33561380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
    Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
    Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
    Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
    J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients.
    Sulistyani LD; Julia V; Soeprapto A; Swari RP; Rosmanato F; Haryanto B; Cahyarini C; Panjaitan R; Maharani DA
    F1000Res; 2022; 11():1238. PubMed ID: 38988895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.
    Song R; Zeng G; Yu J; Meng X; Chen X; Li J; Xie X; Lian X; Zhang Z; Cao Y; Yin W; Jin R
    Emerg Microbes Infect; 2023 Dec; 12(1):2212806. PubMed ID: 37157134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic-based failure of a detergent virucidal for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) nasal infections: A preclinical study and randomized controlled trial.
    Esther CR; Kimura KS; Mikami Y; Edwards CE; Das SR; Freeman MH; Strickland BA; Brown HM; Wessinger BC; Gupta VC; Von Wahlde K; Sheng Q; Huang LC; Bacon DR; Kimple AJ; Ceppe AS; Kato T; Pickles RJ; Randell SH; Baric RS; Turner JH; Boucher RC
    Int Forum Allergy Rhinol; 2022 Sep; 12(9):1137-1147. PubMed ID: 35040594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Povidone-Iodine Solution: A Potential Antiseptic to Minimize the Risk of COVID-19? A Narrative Review.
    Castro-Ruiz C; Vergara-Buenaventura A
    J Int Soc Prev Community Dent; 2020; 10(6):681-685. PubMed ID: 33437699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
    Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
    BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial.
    Tandon M; Wu W; Moore K; Winchester S; Tu YP; Miller C; Kodgule R; Pendse A; Rangwala S; Joshi S;
    Lancet Reg Health Southeast Asia; 2022 Aug; 3():100036. PubMed ID: 35784831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers.
    Imsuwansri T; Jongthitinon T; Pojdoung N; Meesiripan N; Sakarin S; Boonkrai C; Wongtangprasert T; Phakham T; Audomsun T; Attakitbancha C; Saelao P; Muanwien P; Tian MT; Tongchusak S; Sangruji B; Wannigama DL; Sawangmake C; Rodprasert W; Le QD; Purbantoro SD; Vasuntrarak K; Nantavisai S; Sirilak S; Uppapong B; Sapsutthipas S; Trisiriwanich S; Somporn T; Usoo A; Mingngamsup N; Phumiamorn S; Aumklad P; Arunprasert K; Patrojanasophon P; Opanasopit P; Pesirikan N; Nitisaporn L; Pitchayakorn J; Narkthong T; Mahong B; Chaiyo K; Srisutthisamphan K; Viriyakitkosol R; Aeumjaturapat S; Jongkaewwattana A; Bunnag S; Pisitkun T
    Sci Rep; 2023 Sep; 13(1):15648. PubMed ID: 37730833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinical study on the tolerability of a liposomal povidone-iodine nasal spray: implications for further development.
    Gluck U; Martin U; Bosse B; Reimer K; Mueller S
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(2):92-9. PubMed ID: 17148942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.